<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">313366</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Cell technology</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Новости клеточных технологий</subject></subj-group><subj-group subj-group-type="article-type"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Xenotransplantation of Neuronal Cells in Patients with Ischemic Stroke - Results of Phase I Clinical Trials</article-title><trans-title-group xml:lang="ru"><trans-title>Ксенотрансплантация нейрональных клеток пациентам с ишемическим инсультом - результаты I фазы клинических испытаний</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bersenev</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Берсенев</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2005-07-06" publication-format="electronic"><day>06</day><month>07</month><year>2005</year></pub-date><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>26</fpage><lpage>27</lpage><history><date date-type="received" iso-8601-date="2023-03-04"><day>04</day><month>03</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-03-04"><day>04</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Эко-Вектор</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/313366">https://genescells.ru/2313-1829/article/view/313366</self-uri><abstract xml:lang="ru"><p/></abstract><trans-abstract xml:lang="en"><p/></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Savitz S.I., Rosenbaum D.M., Dinsmore J.H., Wechsler L.R., Caplan L.R. Cell transplantation for stroke. Ann. Neurol. 2002; 52: 266-75.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Bonn D. First cell transplant aimed to reverse stroke damage. Lancet 1998; 352; 9122: 119.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Kondziolka D., Wechsler L., Goldstein S. et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000; 55: 565-9.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Nelson P.T., Kondziolka D., Wechsler L. et al. Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am. J. Pathol. 2002; 160: 1201 -6.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kondziolka D., Steinberg G.K., Cullen S.B., McGrogan M. Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant. 2004; 13:749-54.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Isacson O., Deacon T.W., Pakzaban P. et al. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat. Med. 1995; 1: 1189-94.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Dinsmore J.H. M.J., Siegan J., Morrison J.P. et al. CNS grafts for treatment of neurologic disorders. Methods of Tissue Engineering, San Diego, Academic Press, 2002.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kondziolka D., Steinberg G.K., Wechsler L. et al. Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J. Neurosurg. 2005; 103(1):38-45.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Deacon T.W., Pakzaban P., Burns L.H. et al. Cytoarchitectonic development, axon-glia relationships, and long distance axon growth of porcine striatal xenografts in rats. Exp. Neurol. 1994; 130: 151-67.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Deacon T., Schumacher J., Dinsmore J. et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 1997; 3: 350-3.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bang O.Y., Lee J.S., Lee P.H., Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 2005; 57: 874-82.</mixed-citation></ref></ref-list></back></article>
